199 related articles for article (PubMed ID: 21619508)
21. Oxadiazole-2-oxides may have other functional targets, in addition to SjTGR, through which they cause mortality in Schistosoma japonicum.
Song LJ; Luo H; Fan WH; Wang GP; Yin XR; Shen S; Wang J; Jin Y; Zhang W; Gao H; Liu Q; Wang WL; Feng B; Yu CX
Parasit Vectors; 2016 Jan; 9():26. PubMed ID: 26791563
[TBL] [Abstract][Full Text] [Related]
22. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
Huang J; Hua W; Li J; Hua Z
Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
[TBL] [Abstract][Full Text] [Related]
23. Identification of oxadiazoles as new drug leads for the control of schistosomiasis.
Sayed AA; Simeonov A; Thomas CJ; Inglese J; Austin CP; Williams DL
Nat Med; 2008 Apr; 14(4):407-12. PubMed ID: 18345010
[TBL] [Abstract][Full Text] [Related]
24. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
[TBL] [Abstract][Full Text] [Related]
25. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
26. New insight into praziquantel against various developmental stages of schistosomes.
Wu W; Wang W; Huang YX
Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
[TBL] [Abstract][Full Text] [Related]
27. Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition.
Caroli A; Simeoni S; Lepore R; Tramontano A; Via A
Biochem Biophys Res Commun; 2012 Jan; 417(1):576-81. PubMed ID: 22177949
[TBL] [Abstract][Full Text] [Related]
28. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
[TBL] [Abstract][Full Text] [Related]
29. Potent Inhibitors of Thioredoxin Glutathione Reductase: Grail of Anti-Schistosome Drug within Reach?
Tripathi T; Chetri PB
ACS Infect Dis; 2020 May; 6(5):893-895. PubMed ID: 32159329
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
Xiao SH; Sun J; Chen MG
Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
[TBL] [Abstract][Full Text] [Related]
31. QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.
Melo-Filho CC; Dantas RF; Braga RC; Neves BJ; Senger MR; Valente WC; Rezende-Neto JM; Chaves WT; Muratov EN; Paveley RA; Furnham N; Kamentsky L; Carpenter AE; Silva-Junior FP; Andrade CH
J Chem Inf Model; 2016 Jul; 56(7):1357-72. PubMed ID: 27253773
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
Abo-Ghalia MH; Soliman AE
Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
34. Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.
Gaba S; Jamal S; Open Source Drug Discovery Consortium ; Scaria V
ScientificWorldJournal; 2014; 2014():957107. PubMed ID: 25629082
[TBL] [Abstract][Full Text] [Related]
35. [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.
Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Gasser RB; Keiser J; Gasser G
Chemistry; 2013 Feb; 19(7):2232-5. PubMed ID: 23296750
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
[TBL] [Abstract][Full Text] [Related]
37. Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni.
de Souza Neto LR; Montoya BO; Brandão-Neto J; Verma A; Bowyer S; Moreira-Filho JT; Dantas RF; Neves BJ; Andrade CH; von Delft F; Owens RJ; Furnham N; Silva-Jr FP
Sci Rep; 2024 Jan; 14(1):1582. PubMed ID: 38238498
[TBL] [Abstract][Full Text] [Related]
38. Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.
Postigo MP; Guido RV; Oliva G; Castilho MS; da R Pitta I; de Albuquerque JF; Andricopulo AD
J Chem Inf Model; 2010 Sep; 50(9):1693-705. PubMed ID: 20695479
[TBL] [Abstract][Full Text] [Related]
39. On the mechanism and rate of gold incorporation into thiol-dependent flavoreductases.
Saccoccia F; Angelucci F; Boumis G; Brunori M; Miele AE; Williams DL; Bellelli A
J Inorg Biochem; 2012 Mar; 108():105-11. PubMed ID: 22166353
[TBL] [Abstract][Full Text] [Related]
40. Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation.
Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Keiser J; Gasser G
J Med Chem; 2012 Oct; 55(20):8790-8. PubMed ID: 23005702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
